CASPIAN: OS results from a randomised Phase III study of first-line Durvalumab +/- Tremelimumab plus chemotherapy in ED-SCLC: OS-Ergebnisse von CASPIAN, einer randomisierten Phase-III-Studie zur Erstlinientherapie von Durvalumab +/- Tremelimumab

Reinmuth N., Paz-Ares L., Chen Y., Hotta K., Trukhin D., Statsenko G., ...More

PNEUMOLOGIE, vol.74, 2020 (ESCI, Scopus)

  • Publication Type: Article / Abstract
  • Volume: 74
  • Publication Date: 2020
  • Doi Number: 10.1055/s-0039-3403350
  • Journal Name: PNEUMOLOGIE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE
  • Istanbul University-Cerrahpasa Affiliated: No